	Cofilin 1 Is an Extracellular Vesicle-Associated Plasma Biomarker of Parkinson's Disease in Humans. Ann Neurol Chandran D, Agrawal U, Damayanthi D, Nair DT, Mandagini G, Nair SS, Narasimhaiah D, Fernandez FB, Thakur P, Raghavan CT, Krishnan S, Gopala S, Urulangodi M. PMID: 42677823 [PubMed - as supplied by publisher]
	Serum VIP and IL-1Î² Levels Are Associated With Anxiety and Depression in Patients With Parkinson's Disease: A Cross-Sectional Study. Brain Behav Li L, Jia X, Shi Y, Yuan Z, Niu C, Huang Y, Zhang X, Li H, Han T, Cui Y, Fei P, Wang G, Du A. PMID: 42677804 [PubMed - indexed for MEDLINE]
	Pain and sensory abnormalities in prodromal and early Parkinson's disease: mechanisms, assessment, and clinical implications. Front Pain Res (Lausanne) Andersen MS, Oppel LM, Modrau B, Jensen K, Gazerani P. PMID: 42676769 [PubMed]
	Role of STX1A in Parkinson's disease: evidence, mechanistic hypotheses, and translational perspectives. Front Aging Neurosci Xu R, Li R, Li H, Li Q, Li Y, Wu G, Dong X. PMID: 42676507 [PubMed]
	Rebalancing Î±-Synuclein Clearance: Novel Therapeutic Frontiers in Parkinson's Disease. Neuromolecular Med Jabeen M, Hameed H, Ahmad SM, Mushtaq T, Khan MA, Hameed A. PMID: 42675202 [PubMed - indexed for MEDLINE]
	Harnessing the neuroprotective potential of estrogen in Parkinson's disease: an insight into molecular mechanisms and therapeutic approaches. Metab Brain Dis Kaur A, Sharma A, Upadhayay S. PMID: 42671470 [PubMed - indexed for MEDLINE]
	Supporting Medication Adherence in Parkinson's Through Education: A Scoping Review of Interventions. Health Expect Haworth H, Carter G, Rogers KMA, Mitchell G, Jacobs L, Stark P. PMID: 42670214 [PubMed - indexed for MEDLINE]
	A single-cell meta-analysis evidences transposable element dysregulation in sex-based differences in Parkinson's disease. Neurobiol Dis Gordillo-González F, Galiana-Roselló C, Grillo-Risco R, Soler-Saéz I, Hidalgo MR, Siomi H, Kobayashi-Ishihara M, García-García F. PMID: 42669364 [PubMed - as supplied by publisher]
	Nanotechnology-enabled delivery of bioactive compounds for neuroprotection in Parkinson's disease: mechanisms and future directions. J Biomater Sci Polym Ed Gaur P, Bisht PR, Lal Gupta S. PMID: 42667129 [PubMed - as supplied by publisher]
	The effects of nicotine on Parkinson's disease: A systematic review and meta-analysis of experimental evidence. IBRO Neurosci Rep Bereda G, Ahamad J. PMID: 42667100 [PubMed]
	GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease. Front Neurosci Hölscher C. PMID: 42666495 [PubMed]
	Effects of Tai Chi on functional performance and fall-related psychological outcomes in Parkinson's disease: a systematic review and meta-analysis. Front Aging Neurosci Wang F, Hao T. PMID: 42666353 [PubMed]
	Plasma Î±-synuclein and QSM-derived susceptibility in Parkinson's disease: associations with clinical features. Front Aging Neurosci Li X, Luo T, Bai J. PMID: 42666293 [PubMed]
	Diagnostic value of multi-regional multi-parameter transcranial sonography in differentiating Parkinson's disease from essential tremor. Front Neurol Yao H, Wang W, Hu C, Liang X, Zhang L. PMID: 42666226 [PubMed - indexed for MEDLINE]
	Multitargeted drug strategies for Alzheimer's and Parkinson's diseases. Z Naturforsch C J Biosci Khan AU, Abdullah A, Naqvi SF, Tahir H, Khalid H, Sarfraz H, Khan Y. PMID: 42666058 [PubMed - as supplied by publisher]
	Effects of Aquatic Tai Chi and Computer Assisted Rehabilitation Environment-Based Virtual Reality Training on Rehabilitation in Patients with Parkinson Disease: A Randomized Controlled Trial. Arch Phys Med Rehabil Zhang X, Hou W, Jin Q, Wang S, Zhou J, Yang C, Jiao J. PMID: 42665222 [PubMed - as supplied by publisher]
	Trans-spinal theta burst magnetic stimulation combined with treadmill training for gait disorders in Parkinson's disease: A randomized clinical trial. Parkinsonism Relat Disord Lopes LKR, Oliveira JR, Costa-Ribeiro A, Monte-Silva K, Souza CDO, Melo MCSD, Gomes MLA, Shirahige L, Albuquerque RM, Carra RB, Nunes GA, Martins PN, Tanaka C, Barbosa ER, Andrade DCD, Cury RG. PMID: 42664922 [PubMed - as supplied by publisher]
	The triglyceride-glucose index in parkinsonian syndromes: a clinical dead end or a hint at central dysregulation? Neurol Neurochir Pol Buczek A, Jaworska E, Bigajski H, W, Chmiela T, Siuda J. PMID: 42663389 [PubMed - indexed for MEDLINE]
	Glucagon-like peptide-1 receptor agonists and the risk of Parkinson's disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data. Front Endocrinol (Lausanne) Chen Y, Wang X, Wang J, Ma G. PMID: 42661791 [PubMed - indexed for MEDLINE]
	Biological heterogeneity in Parkinson's disease: implications for MRI-based patient stratification. NPJ Parkinsons Dis Pokotylo MM, Brüggemann N, Prasuhn J. PMID: 42660962 [PubMed]

Articles 1 - 20 / 58692

Page 1 of 2935



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy